We have previously used a defective herpes simplex virus vector to express a foreign gene in the adult rat brain. One application of this technology would be the in vivo analysis of promoter function in brain after de novo transfer, which would allow the rapid generation of vectors with localized application in a broad range of mammalian species while avoiding influences of other nearby promoters. A 2.7-kb fragment of the rat preproenkephalin promoter was placed upstream of the bacterial lacZ gene in our herpes simplex virus amplicon. A restricted pattern of lacZ expression was observed in vivo, which follows previously observed patterns of endogenous preproenkephalin expression. These results, from the direct gene transfer into an adult animal brain for in vivo promoter analysis, demonstrate that sequence information that influences restricted expression of preproenkephalin is located within 2.7 kb upstream of transcriptional initiation. lacZ expression was also observed in rat brain for 2 months after direct transfer, and PCR analysis confirmed the continued presence of amplicon DNA in lacZ-positive sections. Restricted and long-term expression observed with an endogenous promoter has important implications for gene therapy using viral vectors.
HSV gene products. Any promoter and reporter gene combination can be placed in the amplicon according to the desired application, resulting in the transfer of only a single selected functional transcription unit. In the presence of a helper virus, the amplicon is amplified to genome size (-150 kb) and packaged into an HSV particle, creating a defective viral vector (1) (2) (3) (4) (5) (6) . The defective HSV vector is thus incapable of autonomous replication in the absence of helper virus. Defective HSV vectors express foreign genes in both nonneuronal (2) and neuronal (7) cells in tissue culture and in vivo in the rat central nervous system (5) and peripheral nervous system (8) .
One use of the defective HSV vector would be as a vehicle for the analysis of promoter function in vivo. This technique should combine the advantages of plasmid-based systems, which have been widely utilized for promoter analysis in tissue culture (9, 10) , with the ability to assay promoter function in vivo. This would be of particular utility in the central nervous system and would provide an alternative to the transgenic mouse (11) , which is currently the major vehicle for in vivo promoter analysis. Potential benefits ofthe defective HSV system for promoter analysis include rapid and simple generation of vectors, and compatibility with many mammalian species, due to the broad host range of HSV (12) , whereas transgenic technology is usually limited to mice. Finally, as an episomal vector injected into the fully developed adult animal, the defective HSV vector should not be subject to variables such as effects of insertion within the host chromosome or developmental modification.
The rat preproenkephalin (PPE) promoter was chosen for analysis due to the complex patterns of endogenous PPE expression (13) (14) (15) (16) and regulation in neural and neuroectoderm-derived tissues (13, 15, 16) . Within the brain, PPE is produced in a highly specific pattern, with expression limited to discrete brain regions (13) (14) (15) (16) (17) (18) (19) , including caudate nucleus, amygdala, piriform cortex, olfactory tubercle, and ventromedial hypothalamus (15, 16) .
The current study reports the use of direct gene transfer for analysis of the activity of an endogenous cellular promoter in vivo. The results demonstrate that a 2.7-kb fragment ofthe rat PPE promoter yields substantial expression of the lacZ reporter gene in several brain regions that express endogenous PPE transcripts, whereas no lacZ expression was noted in a brain region that lacks endogenous PPE transcripts.
MATERIALS AND METHODS
Construction of Plasmid pHENK and Derivatives. A 2.7-kb Avr II-Sac I fragment of the rat PPE promoter was isolated from plasmid pRESSi (14) . This fragment was inserted into the polylinker of plasmid pSL301 (Invitrogen) and then removed by cutting with Avr II and Msc I. To (20) . Three animals were tested per region, and the pattern of expression for each region was reproduced in all animals. For regional distribution, animals were sacrificed 3 days after surgery, while long-term expression was examined after 2 months. The titer of dvHENK.2700 was 4 x 107 defective particles per ml, and the titers of the deleted forms were 1 x 108 defective particles per ml. All brains were processed and stained for 5-bromo-4-chloro-3-indolyl /3-Dgalactoside histochemistry (5) .
PCR Analysis of Defective Vector DNA from Fixed and Stained Sections. After photography, coverslips were floated off and sections were rehydrated. Regions consisting of W10 mm2 around the injection site were scraped off, placed into 0.6-ml tubes, and processed for "nested" PCR as described (21) . Primers were directed against the lacZ gene. Primers for reaction A were lacZ182 (5'-CCGACTGATGCCTTCTGAA-CAA-3') and lacZ560 (5 '-GACGACAGTATCGGCCT-CAGGA-3'). A 1:1000 dilution (1 ul) of products from reaction A was utilized for reaction B, with primers lacZ211 (5'-GCATTATTGCCGTAAGCCGTGG-3') and lacZ470 (5'-ATTCAGGCTGCGCAACTGTTGG-3'). Other components were from a standard PCR kit (Cetus). The cycling parameters were 1 min at 940C, 1 min at 60'C, and 1 min at 720C for 35 cycles. Reaction products were analyzed by electrophoresis on a 1.5% agarose gel.
In Situ Hybridization. In situ hybridization to detect endogenous PPE transcripts was performed as described (16, 22) . Probes were generated from a PPE cDNA generated by reverse transcriptase/PCR and obtained from P. J. Brooks (Rockefeller University). (Fig. 2) . In situ hybridization revealed that endogenous PPE mRNA was localized to the pyramidal cell layer of the piriform cortex (Fig. 2B) , which directly paralleled the pattern of lacZ expression under the control of the 2.7-kb PPE promoter in a separate animal ( Fig.  2A) . These data are consistent with a specific pattern of endogenous PPE expression characteristic ofcells within this region (15, 16 (15, 16) . Some positive cells were observed in the dorsolateral thalamus (Fig. 1C) . In contrast, no positive cells were observed in the dorsolateral neocortex of any animal injected in this region (Fig. 3B) , an absence that would be predicted from the lack of endogenous PPE transcripts in this region. Despite the presence of a needle track within the substance of the neocortex, it was still possible that a negative result was due to physical loss of defective viral particles during or after surgery. To address this question, coverslips were floated off stained sections and "nested" PCR analysis was performed. "Nested" PCR involves two successive reactions, with the second reaction using a sample of DNA from the first reaction. The primers from the second reaction are internal to the first, which increases the specificity of the final amplified product, since it is extremely unlikely that a nonspecific product from reaction A would be reamplified with the internal primers from reaction B. The results show that dvHENK DNA was present in both the amygdala and the dorsolateral cortex (Fig. 3D) , even though lacZ expression was only observed in the amygdala. No DNA was present in an uninjected region of the same brain, as expected.
RESULTS
Several controls were performed to eliminate the possibility that nonspecific factors from the vector influenced the observed expression pattern. As a positive control for expression in the dorsolateral neocortex, defective vector dvHCL was injected. This vector contains the human cytomegalovirus (HCMV) IE promoter driving expression of lacZ and has been described (5). Numerous positive cells were repeatedly observed (Fig. 3A) , demonstrating that there is no inability for defective HSV vectors to transfer and express the IacZ gene in this region. As a negative control for expression in the caudate nucleus and amygdala/piriform region, deletions were generated in the enkephalin promoter. Three vectors were generated that contain 1431 bp, 841 bp, or 500 bp upstream from the PPE transcriptional start site. Vectors were titered in the manner used to titer the vector with a 2700-bp fragment. Approximately 200,000 defective vector particles were infused into each region of each subject in a total volume of 2 A1, and all animals were sacrificed 3 days after vector injection. In the amygdala/piriform region, >104 positive cells were observed using dvHENK.2700, while an average of 132, 58, and 107 positive cells were observed with vectors containing 1431-bp, 841-bp, and 500-bp PPE promoter fragments, respectively (n = 3). Similar results were obtained in the caudate nucleus. Again >104 positive cells were observed using dvHENK.2700, while 66, 32, and 128 positive cells were observed with vectors containing 1431-bp, 841-bp, and 500-bp PPE promoter fragments, respectively (n = 2). Finally, we have earlier generated vectors that utilized a 1.1-kb fragment of the rat vasopressin promoter (obtained from D. Richter, University of Hamburg, Germany) to drive expression of the lacZ gene. The amplicon used was identical to that used in the current study, and although packaged viral vectors were obtained, no lacZ expression was ever observed after injection into any rat brain region, including those containing vasopressin-expressing cells. In total, the above data suggest that the absence of positive cells after injection of dvHENK into dorsolateral neocortex was due to a lack of adequate PPE promoter activity, and lacZ expression observed in the caudate nucleus and amygdala/piriform cortex was driven primarily by elements contained within the 2700-bp rat PPE promoter.
Defective we also wanted to determine whether this would permit long-term expression of a foreign gene in the adult brain. Rats were injected with dvHENK in the amygdala and the ventromedial hypothalamus. Two months after injection, positive cells were observed in both regions (Fig. 4 Upper). We then extended the histochemical assay with PCR analysis of dvHENK DNA, as described earlier. Bands of the predicted size were observed in PCR products from three lacZexpressing sections (Fig. 4 Lower), thereby demonstrating that defective HSV DNA can be maintained stably in vivo.
DISCUSSION
The defective HSV vector possesses many features advantageous for in vivo promoter analysis. This system is plasmidbased and episomal; potentially confounding cis-acting influences are thereby minimized (23, 24) . Moreover, promoters from any mammalian species can be studied within the same species. Using the defective HSV vector system, we have demonstrated that a 2.7-kb fragment of the rat PPE promoter is functional in several discrete regions where the endogenous gene is expressed, while it did not function in the dorsolateral neocortex, where endogenous PPE transcripts are also not normally observed. Thus, the defective HSV vector system can provide an alternative to transgenic mouse technology for in vivo promoter analysis.
Recently, there have been attempts to examine PPE promoter function by using transgenic mice (25, 26) . When a 200-bp fragment of the human PPE promoter was employed, significant differences were noted between the gross regional patterns of reporter gene and endogenous PPE expression within the brain (25) . Another study reported very little reporter expression in brains of transgenic mice using a 1.6-kb fiagment of the rat PPE promoter, although very high expression was observed in the testis (26) . This is in contrast to the endogenous pattern of PPE expression, which is far higher in the brain than in testis (27, 28) . In the current study, a larger PPE promoter fragment was employed, and the rat promoter was studied within the rat brain. Both factors may have contributed to our observations of restricted expression consistent with endogenous PPE distribution. We have also observed that deletion of the PPE promoter in dvHENK to 1.4 kb upstream of transcription initiation results in an =100-fold decrease in lacZ expression in the caudate and amygdala/piriform cortex. This is consistent with the low level of expression in brains of transgenic mice with the 1.6-kb fragment of the rat PPE promoter. Furthermore, limited expression from deleted forms of the PPE promoter and a complete absence of lacZ expression when a small fragment of the rat vasopressin promoter was used indicate that the majority of expression from our vector is due to elements within the 2.7-kb rat PPE promoter fragments with little influence from other sequences within the vector. Finally, while the defective HSV vector carries within the virion a transcriptional activating protein, VP16, this protein requires a specific HSV recognition sequence (29) , which is not present in either the HSV sequences in our plasmid or within the known PPE promoter sequence. It is therefore unlikely that this factor significantly influenced our results. Positive cells were unexpectedly observed in the dorsolateral thalamic region, suggesting that this region contains factors that permit transcription from the PPE promoter. It is possible that an element that silences transcription in thalamus is present beyond the 2.7-kb sequence used in this study, and complex combinations of enhancers and silencers have been found in regulatory regions of other genes expressed in brain (30, 31) . In addition, observations of PPE RNA in brain cell types previously thought to lack such transcripts, including the reticular nucleus of the thalamus, indicate that previous hybridization studies may not have completely charProc. Natl. Acad. Sci (17) . In contrast, the lack of transcription in the dorsolateral neocortex indicates that this region is incapable of supporting PPE promoter activity, which is consistent with the absence of endogenous PPE transcripts. We have more recently obtained additionally supportive findings in the hypothalamus. There is intense endogenous PPE expression in the ventromedial hypothalamus, whereas few transcripts have been noted in the lateral hypothalamic area (16) . Injection of dvHENK into the ventromedial hypothalamus can result in many positive cells, but injection into the lateral hypothalamic area yields far fewer positive cells (J. Yin, M.G.K., A.D.K., and D.W.P., unpublished data).
Using the PPE promoter, we also report the demonstration of long-term expression ofa foreign gene in the adult rat brain after direct in vivo transfer via a defective HSV vector. Earlier, we observed expression in rat brain of lacZ under the control of the HCMV IE promoter (5), which was limited to 2 weeks after viral injection. This was consistent with other in vivo studies using the HCMV IE promoter (34, 35) . Although down-regulation of promoter function would have explained this result, it was also possible that either the vector DNA was degraded with time or that cells containing the transferred gene may have died. Stable maintenance of defective HSV DNA has not previously been reported, but PCR analysis of stained sections confirms that defective HSV vector DNA is stable within at least some cells of the rat brain. The replacement of a viral IE promoter with a promoter for an endogenous cellular gene resulted in long-term (2 month) expression. It should be noted that long-term expression in the rat brain has recently been reported using a recombinant adenoviral vector (36) . The current system is a defective virus with a plasmid-based genome, however, and it is unclear as to whether factors influencing the stability of such genomes would be analogous to those influencing recombinant adenovirus or herpesvirus genomes. Although there appears to be a decrease in the number of positive cells with time, the data reported here indicate that ampliconbased genomes are stable for at least 2 months and that long-term expression can be achieved through the use of appropriate promoters.
Our results also have implications for the emerging field of direct gene transfer as a therapeutic modality. Although regulating and maintaining expression of a foreign gene in vivo is difficult, it is central to the continued development of approaches to genetic therapy (37) . The observation that defective HSV vector DNA can be stably maintained in vivo suggests that such vectors are applicable for long.term expression studies. Locally restricted long-term PPE promoterdriven expression in brain further indicates that certain promoters may allow specifically targeted and stable production of a foreign gene product in vivo. The combination of defective HSV vectors and endogenous cellular promoters may provide both additional approaches to understanding gene regulation in vivo and opportunities for genetic therapy through stable modification of the physiology of nondividing terminally differentiated cells.
